摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-cyanothiophene-2-carboximidamide | 73631-24-0

中文名称
——
中文别名
——
英文名称
N'-cyanothiophene-2-carboximidamide
英文别名
——
N'-cyanothiophene-2-carboximidamide化学式
CAS
73631-24-0
化学式
C6H5N3S
mdl
——
分子量
151.192
InChiKey
PZZHXJWZEOFZPE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    230-232 °C
  • 沸点:
    233.7±32.0 °C(Predicted)
  • 密度:
    1.33±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    90.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N'-cyanothiophene-2-carboximidamide盐酸羟胺 作用下, 以 吡啶甲醇 为溶剂, 反应 24.0h, 生成 5-(Thiophen-2-yl)-1,2,4-oxadiazol-3-amine
    参考文献:
    名称:
    Synthesis and diuretic profile of 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, an amiloride-type diuretic
    摘要:
    The synthesis of an analogue of amiloride in which the acylguanidine moiety has been replaced by a 1,2,4-oxadiazol-3-amine unit is described. This substance (3, CGS 4270) exhibited a diuretic profile similar to that of amiloride when evaluated in the rat and the dog. In the rat, combination with hydrochlorothiazide increased diuresis and saluresis and returned potassium levels to control values. A series of 5-aryl-1,2,4-oxadiazol-3-amines not directly related to amiloride was prepared, but these substances had no diuretic activity.
    DOI:
    10.1021/jm00180a025
  • 作为产物:
    描述:
    2-氰基噻吩盐酸potassium carbonate 作用下, 以 甲醇 为溶剂, 反应 102.33h, 生成 N'-cyanothiophene-2-carboximidamide
    参考文献:
    名称:
    Synthesis and diuretic profile of 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, an amiloride-type diuretic
    摘要:
    The synthesis of an analogue of amiloride in which the acylguanidine moiety has been replaced by a 1,2,4-oxadiazol-3-amine unit is described. This substance (3, CGS 4270) exhibited a diuretic profile similar to that of amiloride when evaluated in the rat and the dog. In the rat, combination with hydrochlorothiazide increased diuresis and saluresis and returned potassium levels to control values. A series of 5-aryl-1,2,4-oxadiazol-3-amines not directly related to amiloride was prepared, but these substances had no diuretic activity.
    DOI:
    10.1021/jm00180a025
点击查看最新优质反应信息

文献信息

  • Kinase inhibitors
    申请人:Amgen Inc.
    公开号:US20040116388A1
    公开(公告)日:2004-06-17
    The invention relates to inhibitors of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds, methods of inhibiting phosphoryl transferase activity, and methods for treating disease or disease symptoms.
    这项发明涉及与ATP或GTP结合并/或催化磷酸转移的酶的抑制剂,包括这些抑制剂的组合物,以及使用这些抑制剂抑制剂组合物的方法。这些抑制剂和包含它们的组合物对治疗疾病或疾病症状是有用的。该发明还提供了制备磷酸转移酶抑制剂化合物的方法,抑制磷酸转移酶活性的方法,以及治疗疾病或疾病症状的方法。
  • Carboximidamide derivatives
    申请人:KIRIN BEER KABUSHIKI KAISHA
    公开号:EP0388528A2
    公开(公告)日:1990-09-26
    Novel carboximidamide derivatives represented by the following formula (A) and acid adduct salts thereof are disclosed: wherein all the substituents have the same meanings as defined above. N-cyano-pyridinecarboximidate compounds represented by the following formula (II) whiich are the intermediates for preparing of N-cyano-N′-substituted-­pyridinecarboximidamide derivatives wherein the substituent B in the above described formula (A) is pyridine are also disclosed: wherein all the substituents have the same meanings as defined above. The process for preparing the compounds, the pharmaceutical agents comprising the compound having vasodilating effect, and the therapeutic method of dosing the compound on patients for therapy are also disclosed.
    本发明公开了由下式(A)代表的新型羧亚酰胺衍生物及其酸加成盐: 其中所有取代基的含义与上述定义相同。 还公开了下式(II)代表的 N-氰基吡啶甲脒化合物,它们是制备 N-基-N′-取代的吡啶甲脒生物的中间体,其中上述式(A)中的取代基 B 为吡啶: 其中所有取代基的含义与上述定义相同。 本发明还公开了制备上述化合物的工艺、包含具有血管扩张作用的化合物的药物制剂以及将该化合物用于患者治疗的治疗方法。
  • WATTHEY J. W. H.; DESAI M.; RUTLEDGE R.; DOTSON R., J. MED. CHEM., 1980, 23, NO 6, 690-692
    作者:WATTHEY J. W. H.、 DESAI M.、 RUTLEDGE R.、 DOTSON R.
    DOI:——
    日期:——
  • US5166347A
    申请人:——
    公开号:US5166347A
    公开(公告)日:1992-11-24
  • US5223508A
    申请人:——
    公开号:US5223508A
    公开(公告)日:1993-06-29
查看更多